Gorham–Stout Syndrome with chylothorax: Successful remission by interferon alpha‐2b | Zendy

Kose Mehmet | Zendy; Pekcan Sevgi | Zendy; Dogru Deniz | Zendy; Akyuz Canan | Zendy; Ozcelik Ugur | Zendy; Ozsurekci Yasemin | Zendy; Gulhan Bora | Zendy; Demircin Metin | Zendy; Kiper Nural | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Gorham–Stout Syndrome with chylothorax: Successful remission by interferon alpha‐2b

Author(s) -

Kose Mehmet,

Pekcan Sevgi,

Dogru Deniz,

Akyuz Canan,

Ozcelik Ugur,

Ozsurekci Yasemin,

Gulhan Bora,

Demircin Metin,

Kiper Nural

Publication year - 2009

Publication title -

pediatric pulmonology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.866

H-Index - 106

eISSN - 1099-0496

pISSN - 8755-6863

DOI - 10.1002/ppul.20849

Subject(s) - medicine , chylothorax , complication , alpha interferon , surgery , interferon alfa , interferon , virology

Gorham–Stout syndrome is a rare disease and most often recognized in children and young adults. Chylothorax is a serious complication of Gorham–Stout syndrome. The treatment of either Gorham–Stout syndrome or chylothorax is still a dilemma. We described a 9‐year‐old girl with Gorham–Stout syndrome and chylothorax who was admitted to our hospital because of dyspnea, orthopnea, and bone pain, and treated with interferon alpha‐2b. Pediatr Pulmonol. 2009; 44:613–615. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research